Movano Faces Nasdaq Filing Deadline Notice

The latest update is out from Movano ( (MOVE) ).

On May 20, 2025, Movano Health received a notice from Nasdaq due to a delay in filing its Form 10-Q for the quarter ending March 31, 2025, missing the deadline of May 15, 2025. The company has until July 21, 2025, to submit a compliance plan to Nasdaq, which could extend the deadline to November 11, 2025, if accepted. Failure to comply could lead to further actions, impacting its Nasdaq listing status.

The most recent analyst rating on (MOVE) stock is a Buy with a $30.00 price target. To see the full list of analyst forecasts on Movano stock, see the MOVE Stock Forecast page.

Spark’s Take on MOVE Stock

According to Spark, TipRanks’ AI Analyst, MOVE is a Underperform.

Movano’s stock faces significant challenges primarily due to its weak financial performance, marked by negative profitability and cash flow issues. The technical analysis indicates a bearish trend with poor market momentum, and valuation metrics are unfavorably low. Overall, the stock needs substantial improvement in operational efficiency and market perception to enhance its attractiveness.

To see Spark’s full report on MOVE stock, click here.

More about Movano

Founded in 2018, Movano Inc., operating as Movano Health, is a company focused on developing healthcare solutions that integrate medical-grade data into wearable devices. Their flagship product, the Evie Ring, aims to provide personalized health insights through innovative technology, targeting both consumers and enterprises.

Average Trading Volume: 286,100

Technical Sentiment Signal: Sell

Current Market Cap: $4.36M

See more insights into MOVE stock on TipRanks’ Stock Analysis page.